rs387906237
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000038.6(APC):c.1100_1101delCT(p.Ser367CysfsTer10) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000038.6 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:5
- -
This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. -
This sequence change creates a premature translational stop signal (p.Ser367Cysfs*10) in the APC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in APC are known to be pathogenic (PMID: 17963004, 20685668). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with classic or attenuated familial adenomatous polyposis (PMID: 8544194, 19444466, 20685668). ClinVar contains an entry for this variant (Variation ID: 428117). For these reasons, this variant has been classified as Pathogenic. -
- -
- -
not provided Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1100_1101delCT pathogenic mutation, located in coding exon 9 of the APC gene, results from a deletion of two nucleotides at nucleotide positions 1100 to 1101, causing a translational frameshift with a predicted alternate stop codon (p.S367Cfs*10). This pathogenic mutation has been reported in several families with Familial Adenomatous Polyposis (Bunyan DJ et al. J Med Genet. 1995 Sep;32(9):728-31; Curia MC et al. Hum Mutat. 1998;11(3):197-201; Ficari F et al. Br J Cancer. 2000 Jan;82(2):348-53; Friedl W and Aretz S. Hered Cancer Clin Pract. 2005 Sep 15;3(3):95-114; Lagarde et al. J. Med. Genet. 2010 Oct;47(10):721-2; De Lellis et al. PLoS ONE 2013 Nov;8(11):e81194). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at